Exhibit 32.1
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Remy Luthringer, Chief Executive Officer of Minerva Neurosciences, Inc. (the “Company”), and Frederick Ahlholm, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
Date: March 8, 2023
/s/ Remy Luthringer, Ph.D. |
| /s/ Frederick Ahlholm |
Remy Luthringer, Ph.D. |
| Frederick Ahlholm |
Executive Chairman and Chief Executive Officer |
| Chief Financial Officer
|
|
|
|
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Minerva Neurosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.